Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

6.7%

119 terminated/withdrawn out of 1777 trials

Success Rate

90.8%

+4.3% vs industry average

Late-Stage Pipeline

136 trials in Phase 3/4

Results Transparency

90%

1049 of 1170 completed trials have results

Key Signals

274 recruiting1049 with results78 terminated41 withdrawn

Enrollment Performance

Analytics

N/A

1221(75.7%)

Phase 2

154(9.5%)

Phase 1

80(5.0%)

Phase 4

77(4.8%)

Phase 3

59(3.7%)

Early Phase 1

23(1.4%)

1614Total

N/A(1221)

Phase 2(154)

Phase 1(80)

Phase 4(77)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1777)

Showing 20 of 1777 trials

NCT05842174Phase 1Recruiting

Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma

Role: lead

NCT04390451Not ApplicableCompleted

Initial Testing of Whole Health STEPS

Role: lead

NCT06538636Not ApplicableNot Yet Recruiting

Prediction Augmented Screening Initiative

Role: lead

NCT06788522Phase 4Not Yet Recruiting

The Effects of Orexin Antagonism on Fear Extinction in PTSD

Role: lead

NCT04230512Not ApplicableCompleted

Assessment of a Hybrid Pump for Vacuum Suspension of Prosthetic Sockets for Persons With Lower Limb Loss to Characterize the Effects of Added Movement on Socket-reaction Torques

Role: lead

NCT01138020Not ApplicableCompleted

Cognitive Rehabilitation of Blast Traumatic Brain Injury (TBI)

Role: lead

NCT05516277Not ApplicableRecruiting

Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder

Role: collaborator

NCT06898879Not ApplicableNot Yet Recruiting

Enhancing Veteran-Clinical Collaboration in VA PRRCs

Role: lead

NCT07218354Phase 3Not Yet Recruiting

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder

Role: lead

NCT02404402Not ApplicableCompleted

LED Treatment to Improve Cognition and Promote Recovery in TBI

Role: lead

NCT06850350Recruiting

Cognitive-Sensorimotor Function in Long-COVID

Role: lead

NCT05020587Not ApplicableActive Not Recruiting

Consulting After Combat: Interviewing Veterans to Develop a Therapy to Restore Functioning and Reintegration After Moral Injury Events

Role: lead

NCT05647044Phase 1Recruiting

Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury